Table 1.
Characteristic | Monomicrobial N=51 | Polymicrobial N=18 |
---|---|---|
Age | 69.0 (49.0-81.0) | 78.0 (64.8-82.3) |
Male gender | 35 (68.6) | 10 (55.6) |
Non-white race | 2 (3.9) | 2 (11.1) |
Diabetes mellitus | 12 (23.5) | 1 (5.6) |
End stage renal disease | 5 (9.8) | 0 (0) |
Malignancy | 23 (45.1) | 6 (33.3) |
Hematologic | 10 (19.6) | 3 (16.7) |
Solid tumor | 13 (25.5) | 3 (16.7) |
Immunocompromised | 20 (39.2) | 5 (27.8) |
Chemotherapy | 11 (21.6) | 4 (22.2) |
Corticosteroids | 9 (17.6) | 1 (5.6) |
Neutropenia | 8 (15.7) | 3 (16.7) |
Other immunosuppressive medications | 4 (7.8) | 1 (5.6) |
Transplant recipients | 3 (5.9) | 0 (0) |
Recent surgical procedure | 18 (35.3) | 1 (5.6) |
Central venous catheter | 21 (41.2) | 1 (5.6) |
Foley catheter | 11 (21.6) | 1 (5.6) |
Prior antibiotic therapy | 21 (41.2) | 3 (16.7) |
Classification: | ||
Nosocomial | 11 (21.6) | 1 (5.6) |
Health care-associated | 29 (56.9) | 8 (44.4) |
Community-acquired* | 11 (21.6) | 9 (50.0) |
ICU admission | 12 (23.5) | 7 (38.9) |
Hypotension | 19 (37.3) | 4 (22.2) |
Fever/hypothermia | 32 (62.7) | 13 (72.2) |
Leukocytosis | 27 (52.9) | 9 (52.9) |
Leukopenia | 12 (23.5) | 5 (29.4) |
Pitt bacteremia score ≥ 4 | 11 (21.6) | 4 (22.2) |
Source: | ||
Urinary tract | 16 (31.4) | 4 (22.2) |
Abdominal/biliary** | 1 (2.0) | 5 (27.8) |
Respiratory tract | 11 (21.6) | 4 (22.2) |
Catheter-related | 5 (9.8) | 0 (0) |
Skin and soft tissue | 3 (5.9) | 0 (0) |
Primary bacteremia++ | 15 (29.4) | 5 (27.8) |
28-day all-cause mortality | 13 (25.5) | 4 (22.2) |
Continuous data are expressed as median (interquartile range), whereas categorical data are the observed number (%) for each level.
Primary bacteremia is defined as bacteremia with no clearly established site of active infection.
p=0.022,
p=0.0038 (only p values <0.05 are shown).